+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Interventional Ventricular Assist Devices Market - Global Forecast 2026-2032- Product Image
Interventional Ventricular Assist Devices Market - Global Forecast 2026-2032- Product Image
Sale

Interventional Ventricular Assist Devices Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6151182
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Interventional Ventricular Assist Devices Market is projected to reach USD 2.15 Billion in 2026. It is expected to continue growing at a CAGR of 8.73%, reaching USD 3.56 Billion by 2032.

Interventional Ventricular Assist Devices: Executive Overview

Interventional ventricular assist devices provide temporary mechanical circulatory support during high-risk percutaneous coronary interventions, cardiogenic shock management, and selected acute heart-failure procedures. Their clinical value depends on rapid deployment, hemodynamic support, patient selection, operator expertise, vascular-access management, and integration with intensive-care pathways. Adoption is shaped by evidence quality, reimbursement, hospital readiness, device training, and the availability of multidisciplinary cardiac teams.

Clinical Complexity Is Reshaping Temporary Mechanical Support

The field is shifting from device availability toward protocolized, patient-centered use. Hospitals are emphasizing earlier recognition of hemodynamic deterioration, standardized shock-team activation, imaging-guided access, and coordinated escalation or weaning strategies. At the same time, clinicians are weighing circulatory benefit against bleeding, limb ischemia, hemolysis, vascular injury, infection, and procedural complexity. These priorities are encouraging more rigorous credentialing, outcomes tracking, and selection criteria across interventional cardiology and critical-care services.

Artificial Intelligence Strengthens Selection, Monitoring, and Coordination

Artificial intelligence can support the broader care pathway by identifying patients at elevated risk of deterioration, combining imaging and physiologic data, and helping teams recognize changes in perfusion or device performance. Predictive analytics may also improve case planning, access-site assessment, staffing coordination, and post-procedure surveillance. However, clinical value depends on representative datasets, transparent validation, interoperability with hospital systems, cybersecurity, and clinician oversight. AI should augment multidisciplinary judgment rather than replace it, particularly when evidence is limited or patient conditions evolve rapidly.

Regional Insights: Access, Evidence, and Hospital Readiness Vary

North America is characterized by advanced interventional infrastructure, established shock programs, and strong emphasis on registries, reimbursement, and comparative clinical evidence. Europe combines sophisticated cardiac networks with country-level variation in procurement, funding, and clinical guidance. Asia-Pacific includes highly capable urban centers alongside uneven access to specialized teams, training, and critical-care resources. Latin America is shaped by concentration of advanced services in major metropolitan hospitals and differing reimbursement environments. The Middle East is investing in tertiary cardiac capacity, while referral patterns and workforce availability vary across countries. Africa faces broader constraints in specialized equipment, transport, intensive-care capacity, and trained personnel, making scalable protocols and regional referral networks particularly important.

Group Insights: Economic and Security Blocs Influence Adoption Conditions

ASEAN markets reflect diverse health-system maturity, with adoption influenced by urban concentration, cross-border referral, and local training capacity. BRICS members span substantial differences in manufacturing capability, reimbursement, and access to tertiary cardiac care. The European Union benefits from clinical collaboration and regulatory alignment, although implementation remains nationally differentiated. G7 countries generally have mature cardiovascular infrastructure and stronger evidence-generation capabilities, while NATO members may also benefit from established emergency-response and logistics networks. GCC states are strengthening advanced hospital services, often through centralized investment and international clinical partnerships, but workforce development and long-term integration into national care pathways remain important.

Country Insights: Diverse Pathways for Interventional Support

Australia and Canada combine advanced cardiac centers with geographic challenges that make referral coordination and workforce distribution important. The United States has extensive experience in complex intervention and shock management, with utilization shaped by evidence, hospital protocols, and payer requirements. Brazil and Mexico show the importance of concentrating expertise while improving access beyond leading urban institutions. China and India are expanding sophisticated cardiovascular services, although regional disparities in infrastructure and training persist. Japan and South Korea emphasize high-technology care, procedural quality, and specialized hospital capabilities. France, Germany, Italy, and Spain operate within mature European clinical systems, with differences in procurement, reimbursement, and regional organization. The United Kingdom places strong emphasis on coordinated specialist pathways, governance, and evidence-based adoption. Russia’s access and implementation conditions are influenced by healthcare-system capacity, procurement, and availability of specialized expertise.

Action Priorities for Leaders: Build Safe, Evidence-Led Programs

Industry leaders should prioritize clear patient-selection frameworks, procedure-specific training, and multidisciplinary shock governance rather than treating device deployment as an isolated intervention. Hospitals should establish standardized checklists for access, anticoagulation, monitoring, escalation, and removal; maintain rapid-response teams; and audit complications and patient-centered outcomes. Manufacturers and clinical partners should support independent evidence generation, transparent reporting, interoperable data capture, and training adapted to local resources. Health systems can improve resilience by developing referral networks, simulation programs, remote consultation, and equitable access pathways. AI initiatives should begin with clinically validated use cases and strong safeguards for privacy, bias, cybersecurity, and human accountability.

Research Methodology: Evidence-Based Synthesis of Clinical and System Factors

This executive summary uses a structured qualitative synthesis focused on interventional ventricular assist devices and the factors governing their clinical adoption. The analysis considers peer-reviewed clinical evidence, professional-society guidance, regulatory materials, hospital-care pathways, health-system characteristics, and publicly documented technology trends. Findings are organized across clinical practice, regional systems, economic and geopolitical groupings, and specified countries. Interpretations distinguish established evidence from contextual implications, while avoiding unsupported numerical claims, market estimates, company-specific assessments, and forecasts. Particular attention is given to patient selection, procedural safety, infrastructure, workforce readiness, reimbursement, data governance, and implementation barriers.

Conclusion: Safer Integration Will Define the Next Phase

Interventional ventricular assist devices are becoming increasingly relevant within coordinated strategies for high-risk intervention and acute circulatory support. Their contribution depends less on isolated device capability than on timely diagnosis, appropriate selection, experienced teams, reliable infrastructure, and disciplined follow-up. Regional and country differences will continue to shape implementation, while AI may improve prediction and coordination if deployed responsibly. Leaders who combine rigorous governance, skills development, evidence generation, and equitable referral pathways will be best positioned to integrate temporary mechanical support into safer, more effective cardiovascular care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Interventional Ventricular Assist Devices Market, by Product Component
7.1. Introduction
7.2. Accessories
7.3. Catheter
7.4. Console
8. Interventional Ventricular Assist Devices Market, by Device Type
8.1. Introduction
8.2. Impella
8.2.1. Impella 2.5
8.2.2. Impella 5.0
8.2.3. Impella CP
8.2.4. Impella RP
8.3. Intra Aortic Balloon Pump
8.4. TandemHeart
9. Interventional Ventricular Assist Devices Market, by Indication
9.1. Introduction
9.2. Acute Myocardial Infarction
9.3. Cardiogenic Shock
9.4. High Risk Procedural Support
10. Interventional Ventricular Assist Devices Market, by Patient Age Group
10.1. Introduction
10.2. Adult
10.3. Pediatric
11. Interventional Ventricular Assist Devices Market, by End User
11.1. Introduction
11.2. Hospitals
11.2.1. Cardiac Catheterization Lab
11.2.2. Cardiac Surgery Department
11.2.3. Intensive Care Unit
11.3. Specialized Clinics
12. Interventional Ventricular Assist Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Interventional Ventricular Assist Devices Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Interventional Ventricular Assist Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Abiomed, Inc.
16.3. Berlin Heart GmbH
16.4. Boston Scientific Corporation
16.5. Calon Cardio-Technology Ltd
16.6. CardiacAssist, Inc.
16.7. Carmat SA
16.8. CorWave SA
16.9. Evaheart, Inc.
16.10. FineHeart SRL
16.11. Jarvik Heart, Inc.
16.12. LivaNova plc
16.13. magAssist Co., Ltd.
16.14. Medtronic plc
16.15. ReliantHeart, Inc.
16.16. SynCardia Systems, LLC
16.17. Terumo Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Interventional Ventricular Assist Devices Market, Years Considered for the Study
FIGURE 2. Global Interventional Ventricular Assist Devices Market, Research Design
FIGURE 3. Global Interventional Ventricular Assist Devices Market, Research Framework
FIGURE 4. Global Interventional Ventricular Assist Devices Market, Data Triangulation
FIGURE 5. Global Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Interventional Ventricular Assist Devices Market Size, by Product Component, 2025 vs 2032 (%)
FIGURE 7. Global Interventional Ventricular Assist Devices Market Size, by Product Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Interventional Ventricular Assist Devices Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 9. Global Interventional Ventricular Assist Devices Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Interventional Ventricular Assist Devices Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 11. Global Interventional Ventricular Assist Devices Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 13. Global Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Interventional Ventricular Assist Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Interventional Ventricular Assist Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Interventional Ventricular Assist Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Interventional Ventricular Assist Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Interventional Ventricular Assist Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Interventional Ventricular Assist Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Interventional Ventricular Assist Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Interventional Ventricular Assist Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Interventional Ventricular Assist Devices Market Segmentation & Coverage
TABLE 2. Global Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 4. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Catheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Catheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Catheter Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Console Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Console Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Console Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 14. Global Impella Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Impella Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Impella Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Impella 2.5 Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Impella 2.5 Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Impella 2.5 Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Impella 5.0 Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Impella 5.0 Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Impella 5.0 Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Impella CP Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Impella CP Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Impella CP Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Impella RP Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Impella RP Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Impella RP Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Intra Aortic Balloon Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Intra Aortic Balloon Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Intra Aortic Balloon Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global TandemHeart Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global TandemHeart Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global TandemHeart Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 36. Global Acute Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Acute Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Acute Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Cardiogenic Shock Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Cardiogenic Shock Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Cardiogenic Shock Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global High Risk Procedural Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global High Risk Procedural Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global High Risk Procedural Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 46. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Cardiac Catheterization Lab Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Cardiac Catheterization Lab Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Cardiac Catheterization Lab Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Cardiac Surgery Department Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Cardiac Surgery Department Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Cardiac Surgery Department Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Intensive Care Unit Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Intensive Care Unit Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Intensive Care Unit Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Specialized Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Specialized Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Specialized Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 77. North America Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. North America Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 79. North America Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 80. North America Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 81. North America Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 82. North America Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 83. North America Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. North America Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 85. Latin America Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Latin America Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 87. Latin America Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 88. Latin America Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 89. Latin America Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 90. Latin America Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 91. Latin America Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Latin America Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 93. Europe Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Europe Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 95. Europe Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 96. Europe Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 97. Europe Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 98. Europe Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 99. Europe Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Europe Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 101. Middle East Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Middle East Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 103. Middle East Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 104. Middle East Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 105. Middle East Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 106. Middle East Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 107. Middle East Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Middle East Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 109. Africa Interventional Ventricular Assist Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Africa Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 111. Africa Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 112. Africa Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 113. Africa Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 114. Africa Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 115. Africa Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Africa Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 117. Global Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. ASEAN Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. ASEAN Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 120. ASEAN Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 121. ASEAN Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 122. ASEAN Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 123. ASEAN Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. ASEAN Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 126. GCC Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. GCC Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 128. GCC Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 129. GCC Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 130. GCC Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 131. GCC Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 132. GCC Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. GCC Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 134. European Union Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. European Union Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 136. European Union Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 137. European Union Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 138. European Union Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 139. European Union Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 140. European Union Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. European Union Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 142. BRICS Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. BRICS Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 144. BRICS Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 145. BRICS Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 146. BRICS Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 147. BRICS Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 148. BRICS Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. BRICS Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 150. G7 Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. G7 Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 152. G7 Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 153. G7 Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 154. G7 Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 155. G7 Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 156. G7 Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. G7 Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 158. NATO Interventional Ventricular Assist Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. NATO Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 160. NATO Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 161. NATO Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 162. NATO Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 163. NATO Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 164. NATO Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. NATO Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. Global Interventional Ventricular Assist Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. United States Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 168. United States Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 169. United States Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 170. United States Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 171. United States Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 172. United States Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 173. United States Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. United States Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. Canada Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 176. Canada Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 177. Canada Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 178. Canada Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 179. Canada Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 180. Canada Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 181. Canada Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Canada Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 183. Mexico Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 184. Mexico Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 185. Mexico Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 186. Mexico Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 187. Mexico Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 188. Mexico Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 189. Mexico Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Mexico Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 191. Brazil Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 192. Brazil Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 193. Brazil Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 194. Brazil Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 195. Brazil Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. Brazil Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 197. Brazil Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Brazil Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 199. United Kingdom Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 200. United Kingdom Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 201. United Kingdom Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 202. United Kingdom Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 203. United Kingdom Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 204. United Kingdom Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 205. United Kingdom Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. United Kingdom Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 207. Germany Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 208. Germany Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 209. Germany Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 210. Germany Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 211. Germany Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. Germany Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 213. Germany Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Germany Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. France Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 216. France Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 217. France Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 218. France Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 219. France Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 220. France Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 221. France Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. France Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 223. Russia Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 224. Russia Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 225. Russia Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 226. Russia Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 227. Russia Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 228. Russia Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 229. Russia Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Russia Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. Italy Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 232. Italy Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 233. Italy Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 234. Italy Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 235. Italy Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 236. Italy Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 237. Italy Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Italy Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 239. Spain Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 240. Spain Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 241. Spain Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 242. Spain Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 243. Spain Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 244. Spain Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 245. Spain Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Spain Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 247. China Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 248. China Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 249. China Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 250. China Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 251. China Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 252. China Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 253. China Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. China Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 255. India Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 256. India Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 257. India Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 258. India Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 259. India Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 260. India Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 261. India Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. India Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 263. Japan Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 264. Japan Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 265. Japan Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 266. Japan Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 267. Japan Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 268. Japan Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 269. Japan Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Japan Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 271. Australia Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 272. Australia Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 273. Australia Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 274. Australia Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 275. Australia Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 276. Australia Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 277. Australia Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Australia Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 279. South Korea Interventional Ventricular Assist Devices Market Size, 2017-2032 (USD Million)
TABLE 280. South Korea Interventional Ventricular Assist Devices Market Size, by Product Component, 2017-2032 (USD Million)
TABLE 281. South Korea Interventional Ventricular Assist Devices Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 282. South Korea Interventional Ventricular Assist Devices Market Size, by Impella, 2017-2032 (USD Million)
TABLE 283. South Korea Interventional Ventricular Assist Devices Market Size, by Indication, 2017-2032 (USD Million)
TABLE 284. South Korea Interventional Ventricular Assist Devices Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 285. South Korea Interventional Ventricular Assist Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. South Korea Interventional Ventricular Assist Devices Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 287. Global Interventional Ventricular Assist Devices Market Share, by Key Player, 2025
TABLE 288. Global Interventional Ventricular Assist Devices Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Calon Cardio‑Technology Ltd
  • CardiacAssist, Inc.
  • Carmat SA
  • CorWave SA
  • Evaheart, Inc.
  • FineHeart SRL
  • Jarvik Heart, Inc.
  • LivaNova plc
  • magAssist Co., Ltd.
  • Medtronic plc
  • ReliantHeart, Inc.
  • SynCardia Systems, LLC
  • Terumo Corporation

Related Topics

Related Reports

Ventricular Assist Device Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Ventricular Assist Device Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Ventricular Assist Device Market - Global Forecast 2026-2032 - Product Image

Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
MagLev Ventricular Assist Device Market - Global Forecast 2026-2032 - Product Image

MagLev Ventricular Assist Device Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Ventricular Assist Device Market Report 2026 - Product Image

Ventricular Assist Device Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Ventricular Assist Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Ventricular Assist Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.